Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human-Induced Pluripotent Stem Cells and Herbal Small-Molecule Drugs for Treatment of Alzheimer’s Disease
Liwei Wu, Sheng‐Tzung Tsai, Tzyy‐Wen Chiou, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1327-1327
Open Access | Times Cited: 13

Showing 13 citing articles:

Review on anti-alzheimer drug development: approaches, challenges and perspectives
Abdallah E. Abdallah
RSC Advances (2024) Vol. 14, Iss. 16, pp. 11057-11088
Open Access | Times Cited: 15
Comprehensive Bibliometric Analysis of Stem Cell Research in Alzheimer’s Disease from 2004 to 2022
Rui Wang, Yi Zhu, Lanfang Qin, et al.
Dementia and Geriatric Cognitive Disorders (2023) Vol. 52, Iss. 2, pp. 47-73
Closed Access | Times Cited: 20
Stem Cell Therapy for Alzheimer’s Disease: A Scoping Review for 2017–2022
Yunxiao Duan, Linshuoshuo Lyu, Siyan Zhan
Biomedicines (2023) Vol. 11, Iss. 1, pp. 120-120
Open Access | Times Cited: 15
Parthenolide alleviates cognitive dysfunction and neurotoxicity via regulation of AMPK/GSK3β(Ser9)/Nrf2 signaling pathway
Jinfeng Sun, Liwei Li, Xiong Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115909-115909
Open Access | Times Cited: 11
Targeting PSEN1 by lnc-CYP3A43-2/miR-29b-2-5p to Reduce β Amyloid Plaque Formation and Improve Cognition Function
Liwei Wu, Shinn‐Zong Lin, Shee‐Ping Chen, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10554-10554
Open Access | Times Cited: 13
THE ROLE OF BETA-AMYLOID IN NORM AND AT ALZHEIMER`S DISEASE
Yu. N. Tyshchenko, E. A. Lukyanetz
Fìzìologìčnij žurnal (2020) Vol. 66, Iss. 6, pp. 88-96
Open Access | Times Cited: 6
Advances in the Application of Induced Pluripotent Stem Cells in Alzheimer’s Disease and Parkinson's Disease
Yiran Xu, Shuxia Wang, Ping Zhu
Current Stem Cell Research & Therapy (2022) Vol. 18, Iss. 2, pp. 154-162
Closed Access | Times Cited: 3
The Potential of Induced Pluripotent Stem Cells to Treat and Model Alzheimer’s Disease
Joseph M. Schulz
Stem Cells International (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 4
Generation and Characterization of a Novel Knockin Mouse Model Expressing PSEN1 D385A: Implications for Investigating Herbal Drug Effects in γ-Secretase Activity
Chengeng Deng, Qing-Yuan Cai, Jia-Ni Zhang, et al.
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. 3, pp. 825-841
Closed Access
Natural Inhibitors of Amyloid Aggregation
Paolo Tortora, Francesco A. Aprile
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13310-13310
Open Access | Times Cited: 1
Induced pluripotent stem cells for modeling open-angle glaucoma
Brandon S. Cheuk, Ajay Kumar, Yiqin Du
Elsevier eBooks (2022), pp. 85-104
Closed Access | Times Cited: 1
Effect of plant extracts against Alzheimer’s disease
Magisetty Obulesu
Elsevier eBooks (2022), pp. 1-15
Closed Access | Times Cited: 1
Efficacy and Potential of Stem Cell Therapy for Alzheimer’s Disease
Yusuf Hussain, Poonam Agarwal
Journal of Student Research (2023) Vol. 12, Iss. 1
Open Access
Page 1

Scroll to top